1. Home
  2. OCUL vs DBRG Comparison

OCUL vs DBRG Comparison

Compare OCUL & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • DBRG
  • Stock Information
  • Founded
  • OCUL 2006
  • DBRG 1991
  • Country
  • OCUL United States
  • DBRG United States
  • Employees
  • OCUL N/A
  • DBRG N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • DBRG Real Estate Investment Trusts
  • Sector
  • OCUL Health Care
  • DBRG Real Estate
  • Exchange
  • OCUL Nasdaq
  • DBRG Nasdaq
  • Market Cap
  • OCUL 1.8B
  • DBRG 1.8B
  • IPO Year
  • OCUL 2014
  • DBRG 2009
  • Fundamental
  • Price
  • OCUL $13.60
  • DBRG $11.22
  • Analyst Decision
  • OCUL Strong Buy
  • DBRG Strong Buy
  • Analyst Count
  • OCUL 6
  • DBRG 7
  • Target Price
  • OCUL $17.20
  • DBRG $16.00
  • AVG Volume (30 Days)
  • OCUL 2.2M
  • DBRG 1.8M
  • Earning Date
  • OCUL 08-05-2025
  • DBRG 10-31-2025
  • Dividend Yield
  • OCUL N/A
  • DBRG 0.35%
  • EPS Growth
  • OCUL N/A
  • DBRG N/A
  • EPS
  • OCUL N/A
  • DBRG N/A
  • Revenue
  • OCUL $56,664,000.00
  • DBRG $173,540,000.00
  • Revenue This Year
  • OCUL N/A
  • DBRG N/A
  • Revenue Next Year
  • OCUL $18.87
  • DBRG $61.97
  • P/E Ratio
  • OCUL N/A
  • DBRG N/A
  • Revenue Growth
  • OCUL N/A
  • DBRG N/A
  • 52 Week Low
  • OCUL $5.79
  • DBRG $6.41
  • 52 Week High
  • OCUL $13.82
  • DBRG $17.33
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 68.16
  • DBRG 53.26
  • Support Level
  • OCUL $12.41
  • DBRG $11.05
  • Resistance Level
  • OCUL $12.49
  • DBRG $11.39
  • Average True Range (ATR)
  • OCUL 0.56
  • DBRG 0.30
  • MACD
  • OCUL 0.04
  • DBRG -0.01
  • Stochastic Oscillator
  • OCUL 88.48
  • DBRG 44.99

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

Share on Social Networks: